Cronos Group Inc
TSX:CRON

Watchlist Manager
Cronos Group Inc Logo
Cronos Group Inc
TSX:CRON
Watchlist
Price: 2.7 CAD 1.12% Market Closed
Market Cap: 1B CAD

Cronos Group Inc
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cronos Group Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Cronos Group Inc
TSX:CRON
Cash from Operating Activities
$19m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Canopy Growth Corp
TSX:WEED
Cash from Operating Activities
-CA$165.8m
CAGR 3-Years
33%
CAGR 5-Years
26%
CAGR 10-Years
-51%
Aurora Cannabis Inc
TSX:ACB
Cash from Operating Activities
-CA$8.7m
CAGR 3-Years
53%
CAGR 5-Years
50%
CAGR 10-Years
-11%
Sundial Growers Inc
NASDAQ:SNDL
Cash from Operating Activities
CA$59.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
Cash from Operating Activities
CA$9.1m
CAGR 3-Years
-39%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipher Pharmaceuticals Inc
TSX:CPH
Cash from Operating Activities
$21.3m
CAGR 3-Years
23%
CAGR 5-Years
12%
CAGR 10-Years
2%

Cronos Group Inc
Glance View

Market Cap
1B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.66 CAD
Overvaluation 38%
Intrinsic Value
Price

See Also

What is Cronos Group Inc's Cash from Operating Activities?
Cash from Operating Activities
19m USD

Based on the financial report for Mar 31, 2025, Cronos Group Inc's Cash from Operating Activities amounts to 19m USD.

What is Cronos Group Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
614%

Over the last year, the Cash from Operating Activities growth was 614%.

Back to Top